IRS2 and focal segmental glomerulosclerosis: In another study, increased IRS2 mRNA was detected in DN patients compared to controls, while no significant changes IRS2 expression were present in biopsies from patients with focal-segmental glomerulosclerosis or membranous nephropathy [49].